Vascular-targeted photothermal therapy of an orthotopic murine glioma model

Nanomedicine

Volumn 7, Issue 8, 2012, Pages 1133-1148

  Day, Emily S ^a   Zhang, Linna ^b   Thompson, Patrick A ^b   Zawaski, Janice A ^b   Kaffes, Caterina C ^b   Gaber, M Waleed ^b   Blaney, Susan M ^b   West, Jennifer L ^a  

^a Rice University   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

antiangiogenic therapy; brain tumor; cancer; glioma; nanoparticles; near infrared; thermal therapy; VEGF

Indexed keywords

CELL SURFACE RECEPTOR; MACROGOL; MOLECULAR MARKER; NANOSHELL; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 2;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL; BRAIN TUMOR; CONTROLLED STUDY; CULTURE MEDIUM; ENDOTHELIUM CELL; GLIOMA; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; MICROSCOPY; MOUSE; NANOMEDICINE; NEAR INFRARED THERMAL THERAPY; NONHUMAN; PHOTOTHERAPY; PHOTOTHERMAL THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR CELL CULTURE; VASCULAR TARGETED PHOTOTHERMAL THERAPY;

ANIMALS; BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; ENDOTHELIAL CELLS; GLIOMA; HUMANS; HYPERTHERMIA, INDUCED; MICE; NANOSHELLS; PHOTOTHERAPY; POLYETHYLENE GLYCOLS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84868101856     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.189     Document Type: Article

References (43)

1. Tuettenberg J, Friedel C, Vajkoczy P. Angiogenesis in malignant glioma-a target for antitumor therapy? Crit. Rev. Oncol. Hematol. 59(3), 181-193 (2006). (Pubitemid 44279420)
2. Day E, Thompson P, Zhang L et al. Nanoshell-mediated photothermal therapy improves survival in a murine glioma model. J. Neurooncol. 104(1), 55-63 (2011).
3. Day ES, Morton JG, West JL. Nanoparticles for thermal cancer therapy. J. Biomech. Eng. 131(7), 074001-074005 (2009).
4. Kennedy LC, Bickford LR, Lewinski NA et al. A new era for cancer treatment: gold-nanoparticle-mediated thermal therapies. Small 7(2), 169-183 (2011).
5. Erber R, Thurnher A, Katsen AD et al. Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. FASEB J. 18(2), 338-340 (2004).
6. Keunen O, Johansson M, Oudin A et al. Anti-VEGF treatment reduces blood supply and increases tumor cell invasion in glioblastoma. Proc. Natl Acad. Sci. USA 108(9), 3749-3754 (2011).
7. Hirsch LR, Stafford RJ, Bankson JA et al. Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance. Proc. Natl Acad. Sci. USA 100(23), 13549-13554 (2003). (Pubitemid 37444779)
8. O'Neal DP, Hirsch LR, Halas NJ, Payne JD, West JL. Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett. 209(2), 171-176 (2004). (Pubitemid 38670486)
9. Lu W, Xiong C, Zhang G et al. Targeted photothermal ablation of murine melanomas with melanocyte-stimulating hormone analog-conjugated hollow gold nanospheres. Clin. Cancer Res. 15(3), 876-886 (2009).
10. Dickerson EB, Dreaden EC, Huang XH et al. Gold nanorod assisted near-infrared plasmonic photothermal therapy (PPTT) of squamous cell carcinoma in mice. Cancer Lett. 269(1), 57-66 (2008).
11. Huang X, El-Sayed IH, Qian W, El-Sayed MA. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. J. Am. Chem. Soc. 128(6), 2115-2120 (2006). (Pubitemid 43277351)
12. Day ES, Bickford LR, Slater JH, Riggall NS, Drezek RA, West JL. Antibody-conjugated gold-gold sulfide nanoparticles as multifunctional agents for imaging and therapy of breast cancer. Int. J. Nanomedicine 5, 445-454 (2010).
13. Gobin AM, Watkins EM, Quevedo E, Colvin VL, West JL. Near-infrared- resonant gold/ gold sulfide nanoparticles as a photothermal cancer therapeutic agent. Small 6(6), 745-752 (2010).
14. Au L, Zheng D, Zhou F, Li ZY, Li X, Xia Y. A quantitative study on the photothermal effect of immuno gold nanocages targeted to breast cancer cells. ACS Nano 2(8), 1645-1652 (2008).
15. Li Y, Lu W, Huang Q, Li C, Chen W. In vitro photothermal ablation of tumor cells with CuS nanoparticles. Nanomedicine 5(8), 1161-1171 (2010).
16. Zhou M, Zhang R, Huang M et al. A chelator-free multifunctional [64Cu]CuS nanoparticle platform for simultaneous micro-PET/CT imaging and photothermal ablation therapy. J. Am. Chem. Soc. 132(43), 15351-15358 (2010).
17. El-Sayed IH, Huang X, El-Sayed MA. Selective laser photo-thermal therapy of epithelial carcinoma using anti-EGFR antibody conjugated gold nanoparticles. Cancer Lett. 239(1), 129-135 (2006). (Pubitemid 43946581)
18. Cole JR, Mirin NA, Knight MW, Goodrich GP, Halas NJ. Photothermal efficiencies of nanoshells and nanorods for clinical therapeutic applications. J. Phys. Chem. C 113(28), 12090-12094 (2009).
19. Chen J, Wang D, Xi J et al Immuno gold nanocages with tailored optical properties for targeted photothermal destruction of cancer cells. Nano Lett. 7(5), 1318 (2007).
20. Lowery AR, Gobin AM, Day ES, Halas NJ, West JL. Immunonanoshells for targeted photothermal ablation of tumor cells. Int. J. Nanomedicine 1(2), 149-154 (2006).
21. Huang YF, Sefah K, Bamrungsap S, Chang HT, Tan W. Selective photothermal therapy for mixed cancer cells using aptamer-conjugated nanorods. Langmuir 24(20), 11860-11865 (2008).
22. Matsumura Y, Maeda H. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res. 46(12 Pt 1), 6387-6392 (1986). (Pubitemid 17221789)
23. Chamberlain MC. Antiangiogenesis: biology and utility in the treatment of gliomas. Expert Rev. Neurother. 8(10), 1419-1423 (2008).
24. Choudhury SR, Karmakar S, Banik NL, Ray SK. Role of angiogenesis in the pathogenesis of glioblastoma and antiangiogenic therapies for controlling glioblastoma. In: Glioblastoma: Molecular Mechanisms of Pathogenesis and Current Therapeutic Strategies. Ray SK (Ed.). Springer, Berlin, Germany, 217-241 (2010).
25. Murphy EA, Majeti BK, Barnes LA et al. Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis. Proc. Natl Acad. Sci. USA 105(27), 9343-9348 (2008).
26. Li Z, Huang P, Zhang X et al. RGD-conjugated dendrimer-modified gold nanorods for in vivo tumor targeting and photothermal therapy. Mol. Pharm. 7(1), 94-104 (2009).
27. Reardon DA, Wen PY, Desjardins A, Batchelor TT, Vredenburgh JJ. Glioblastoma multiforme: an emerging paradigm of anti-VEGF therapy. Expert Opin. Biol. Ther. 8(4), 541-553 (2008). (Pubitemid 351570416)
28. Miletic H, Niclou SP, Johansson M, Bjerkvig R. Anti-VEGF therapies for malignant glioma: treatment effects and escape mechanisms. Expert Opin. Ther. Targets 13(4), 455-468 (2009).
29. Plate KH, Breier G, Weich HA, Mennel HD, Risau W. Vascular endothelial growth factor and glioma angiogenesis: coordinate induction of VEGF receptors, distribution of VEGF protein and possible in vivo regulatory mechanisms. Int. J. Cancer 59, 520-529 (1994). (Pubitemid 24357278)
30. Oldenburg SJ, Averitt RD, Westcott SL, Halas NJ. Nanoengineering of optical resonances. Chem. Phys. Lett. 288(2-4), 243-247 (1998). (Pubitemid 128185622)
31. Ahmed N, Ratnayake M, Savoldo B et al. Regression of experimental medulloblastoma following transfer of HER2-specific T cells. Cancer Res. 67(12), 5957-5964 (2007). (Pubitemid 46985032)
32. Gaber MW, Yuan H, Killmar JT, Naimark MD, Kiani MF, Merchant TE. An intravital microscopy study of radiation-induced changes in permeability and leukocyte-endothelial cell interactions in the microvessels of the rat pia mater and cremaster muscle. Brain Res. Protoc. 13, 1-10 (2004). (Pubitemid 38519593)
33. De Jong WH, Hagens WI, Krystek P, Burger MC, Sips A, Geertsma RE. Particle size-dependent organ distribution of gold nanoparticles after intravenous administration. Biomaterials 29(12), 1912-1919 (2008).
34. Niidome T, Yamagata M, Okamoto Y et al. PEG-modified gold nanorods with a stealth character for in vivo applications. J. Control. Release 114(3), 343-347 (2006). (Pubitemid 44310822)
35. Zhu X, Wu S, Dahut WL, Parikh CR. Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis. Am. J. Kidney Dis. 49(2), 186-193 (2007). (Pubitemid 46178407)
36. Folkman J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med. 285(21), 1182-1186 (1971).
37. Carpin L, Bickford L, Agollah G et al. Immunoconjugated gold nanoshell-mediated photothermal ablation of trastuzumab-resistant breast cancer cells. Breast Cancer Res. Treat. 125(1), 27-34 (2011).
38. Knizetova P, Ehrmann J, Hlobilkova A et al. Autocrine regulation of glioblastoma cell cycle progression, viability and radioresistance through VEGF-VEGFR2 (KDR) interplay. Cell Cycle 7(16), 2553-2561 (2008).
39. Choi CHJ, Alabi CA, Webster P, Davis ME. Mechanism of active targeting in solid tumors with transferrin-containing gold nanoparticles. Proc. Natl Acad. Sci. USA 107(3), 1235-1240 (2010).
40. Huang X, Peng X, Wang Y et al. A reexamination of active and passive tumor targeting by using rod-shaped gold nanocrystals and covalently conjugated peptide ligands. ACS Nano 4(10), 5887-5896 (2010).
41. Reddy GR, Bhojani MS, Mcconville P et al. Vascular targeted nanoparticles for imaging and treatment of brain tumors. Clin. Cancer Res. 12(22), 6677-6686 (2006). (Pubitemid 44876835)
42. Schwartz JA, Shetty AM, Price RE et al. Feasibility study of particle-assisted laser ablation of brain tumors in orthotopic canine model. Cancer Res. 69(4), 1659-1667 (2009).
43. Deangelis LM. Brain tumors. N. Engl. J. Med. 344(2), 114-123 (2001).